ICR Shares Intelicare Holdings Limited
ASX · ASXLast in our picks 2026-09-29 — not in the current list; analysis below is from that screen
Micro-cap exposure is highly speculative and lacks the liquidity profile preferred for new capital.
Signal breakdown
- ▸Too illiquid for a high-conviction investable pick.
- ▾Below 50-day MA (-11.62%)
Is ICR a buy right now?
Trend: ICR is trading above the 50-day average (+0.00%), RSI 31 — neutral momentum, with a 3-month return of -13.04%.
Valuation & quality: Intelicare Holdings Limited trades on price-to-book 10.00; fundamentals show net margin -102.7%, return on equity -1057.6%, revenue growth 240.6% year on year.
Our screen: WATCH (score 0) — Micro-cap exposure is highly speculative and lacks the liquidity profile preferred for new capital.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +0.00% | +50.00% | +0.00% | -33.30% | +0.00% | +50.00% | -33.30% | +0.00% |
Fundamentals
Technical signals
About Intelicare Holdings Limited
Intelicare Holdings Limited engages in the research, development, and sale of predictive analytics hardware and software package for use in the aged care, disability, and health industries in Australia.
Sector: Healthcare · Industry: Health Information Services · Australia · Website
Related Semiconductors picks
Browse: all ASX stocks · Semiconductors picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.